FindTrial
Sign In

Changes of heart-typel fatty-acid binding protein levels in children undergoing liver transplantation and its predictive value for early prognosis

Changes of heart-typel fatty-acid binding protein levels in children undergoing liver transplantation and its predictive value for early prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110143
Enrollment
Unknown
Registered
2025-10-09
Start date
2025-10-10
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary atresia

Interventions

H-FABP increased group :none
Non-H-FABP increased group:none

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age<=2 years; 2. Children diagnosed with biliary atresia who are going to undergo parental liver transplantation; 3. Anesthesia grade (ASA grade) is III~IV; 4. Cardiac function grade I~II.

Exclusion criteria

Exclusion criteria: 1. Re-liver transplantation; 2. Preoperative combination of heart, lung, kidney insufficiency and hepatic encephalopathy; 3. Congenital diseases before surgery; 4. Children who refuse to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Heart-type fatty-acid binding protein;—

Countries

China

Contacts

Public ContactChe Lu

Tianjin First Central Hospital

chelu567@163.com+86 182 0225 4762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026